Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial. Mangalesh S, Theodoropoulos P, Chi KY, Nanna MG, et al. Lancet 2026;407:1601.

Read + Share

Amedeo Smart

Independent Medical Education

Mangalesh S, Theodoropoulos P, Chi KY, Nanna MG, et al. Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial. Lancet 2026;407:1601.
PMID: 42035776